Such caution is warranted, given that some of the main principles that drive the two parties’ regulatory approaches are vastly different – and sometimes at odds with one another. For example, the EU has long been committed to the “precautionary principle,” which prevents products that may harm human health from entering the EU market – even if the scientific evidence is not yet conclusive.